Conversion from calcineurin inhibitors to sirolimus of recipients with chronic kidney graft disease grade iii for a period 2003-2011
Background/Aim. Tremendous breakthrough in solid organ transplantation was made with the introduction of calcineurin inhibitors (CNI). At the same time, they are potentially nephrotoxic drugs with influence on onset and progression of renal graft failure. The aim of this study was to evaluate th...
Main Authors: | Ignjatović Ljiljana, Hrvačević Rajko, Jovanović Dragan, Kovačević Zoran, Vavić Neven, Rabrenović Violeta, Tomić Aleksandar, Aleksić Predrag, Drašković-Pavlović Biljana, Dujić Aleksandar, Karan Željko, Maksić Đoko |
---|---|
Format: | Article |
Language: | English |
Published: |
Military Health Department, Ministry of Defance, Serbia
2013-01-01
|
Series: | Vojnosanitetski Pregled |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2013/0042-84501309848I.pdf |
Similar Items
-
De novo cancer avoidance after renal transplantation: A case–control study on low-dose sirolimus combined with a calcineurin inhibitor
by: Kuo-Hsin Chen, et al.
Published: (2015-06-01) -
Efficacy and safety of early tacrolimus conversion to sirolimus after kidney transplantation: Long-term results of a prospective randomized study
by: A E El-Agroudy, et al.
Published: (2017-01-01) -
Protective Effects of Oral Sirolimus Therapy against ESWL-induced Kidney Tissue Damage in Rats
by: Mehmet Necmettin Mercimek, et al.
Published: (2019-09-01) -
Safety and effectiveness of everolimus compared with sirolimus and tacrolimus in preventing kidney transplantation rejection: a systematic review and meta-analysis
by: Morteza Arab Zozani, et al.
Published: (2015-08-01) -
Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea
by: Hee Jung Jeon, et al.
Published: (2018-08-01)